Brain, Vol. 119, No. 6, 2009-2019, 1996
© 1996 Guarantors of Brain
research-article |
Progressive cerebral atrophy in multiple sclerosis A serial MRI study
1 NMR Research Unit, Institute of Neurology 2 Department of Medical Physics and Bio-Engineering, University College London UK
Correspondence to:
Correspondence to: Dr A. J. Thompson, NMR Research Unit, Institute of Neurology, Queen Square, London WC1N 3BG, UK
Summary Recent studies of the spinal cord and cerebellum have highlighted the importance of atrophy in the development of neurological impairment in multiple sclerosis. We have therefore developed a technique to quantify the volume of another area commonly involved pathologically in multiple sclerosis: the cerebral white matter. The technique we describe extracts the brain from the skull on four contiguous 5 mm periventricular slices using an algorithm integrated in an image analysis package, and quantifies their volume. Intra-observer scan-rescan reproducibility was 0.56%. We have applied this technique serially to 29 patients with multiple sclerosis selected for an 18-month treatment trial with a monoclonal antibody against CD4+ lymphocytes (deemed clinically ineffective). A decrease in volume beyond the 95% confidence limits for measurement variation was seen in 16 patients by the end of the 18-month period. The rate of development of atrophy was significantly higher in those who had a sustained deterioration in their Kurtzke expanded disability status scale (EDSS) score compared with those who did not (respective means: –6.4 ml year–1 and –1.8 ml year–1, P < 0.05) but in both groups these changes differed significantly from baseline (P < 0.05). Baseline T2 lesion load, change in T2 lesion load over 18 months and the volume of new gadolinium enhancing lesions on monthly scans for the first 10 months showed no correlation with the development of atrophy. This study demonstrates that progressive cerebral atrophy can be detected in individual patients with multiple sclerosis, correlates with worsening disability and gives additional information to that obtained with conventional MRI. The effect of putative therapies aimed at preventing disability could be objectively assessed by this measure.
multiple sclerosis; MRI; disability; cerebral atrophy; gadolinium enhancement; lesion load; clinical measurement.
Received April 16, 1996. Revised July 29, 1996. Accepted August 5, 1996.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J Furby, T Hayton, V Anderson, D Altmann, R Brenner, J Chataway, R. Hughes, K. Smith, D. Miller, and R Kapoor Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1068 - 1075. [Abstract] [PDF]
|
|
|
|
 |
|
 A Minneboo, B Jasperse, F Barkhof, B M J Uitdehaag, D L Knol, V de Groot, C H Polman, and J A Castelijns Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 917 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Bar-Zohar, F Agosta, D Goldstaub, and M Filippi Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives Multiple Sclerosis, July 1, 2008; 14(6): 719 - 727. [Abstract] [PDF]
|
|
|
|
|
|
V Pueyo, J Martin, J Fernandez, C Almarcegui, J Ara, C Egea, L Pablo, and F Honrubia Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis Multiple Sclerosis, June 1, 2008; 14(5): 609 - 614. [Abstract] [PDF]
|
|
|
|
|
|
D Horakova, J L Cox, E Havrdova, S Hussein, O Dolezal, D Cookfair, M G Dwyer, Z Seidl, N Bergsland, M Vaneckova, et al. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 407 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. D. Henderson, S. A. Trip, P. G. Schlottmann, D. R. Altmann, D. F. Garway-Heath, G. T. Plant, and D. H. Miller An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography Brain, January 1, 2008; 131(1): 277 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Khan Can clinical outcomes be used to detect neuroprotection in multiple sclerosis? Neurology, May 29, 2007; 68(22_suppl_3): S64 - S71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zivadinov, L. Locatelli, D. Cookfair, B. Srinivasaraghavan, A. Bertolotto, M. Ukmar, A. Bratina, C. Maggiore, A. Bosco, A. Grop, et al. I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy Multiple Sclerosis, May 1, 2007; 13(4): 490 - 501. [Abstract] [PDF]
|
|
|
|
|
|
C. Wegner, M. M. Esiri, S. A. Chance, J. Palace, and P. M. Matthews Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology, September 26, 2006; 67(6): 960 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-Q. Li, G. D. Sempowski, S. E. McKenna, D. T. Laskowitz, C. A. Colton, and M. P. Vitek Apolipoprotein E-Derived Peptides Ameliorate Clinical Disability and Inflammatory Infiltrates into the Spinal Cord in a Murine Model of Multiple Sclerosis J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 956 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sepulcre, J. Sastre-Garriga, M. Cercignani, G. T. Ingle, D. H. Miller, and A. J. Thompson Regional Gray Matter Atrophy in Early Primary Progressive Multiple Sclerosis: A Voxel-Based Morphometry Study. Arch Neurol, August 1, 2006; 63(8): 1175 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Confavreux and S. Vukusic Natural history of multiple sclerosis: a unifying concept Brain, March 1, 2006; 129(3): 606 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Richert, T. Howard, J. A. Frank, R. Stone, J. Ostuni, J. Ohayon, C. Bash, and H. F. McFarland Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis Neurology, February 28, 2006; 66(4): 551 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Camp, V. L. Stevenson, A. J. Thompson, G. T. Ingle, D. H. Miller, C. Borras, B. Brochet, V. Dousset, M. Falautano, M. Filippi, et al. A longitudinal study of cognition in primary progressive multiple sclerosis Brain, December 1, 2005; 128(12): 2891 - 2898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Pomeroy, P. M. Matthews, J. A. Frank, E. K. Jordan, and M. M. Esiri Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis Brain, November 1, 2005; 128(11): 2713 - 2721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G T Ingle, J Sastre-Garriga, D H Miller, and A J Thompson Is inflammation important in early PPMS? a longitudinal MRI study J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1255 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sastre-Garriga, G. T. Ingle, D. T. Chard, M. Cercignani, L. Ramio-Torrenta, D. H. Miller, and A. J. Thompson Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study Brain, June 1, 2005; 128(6): 1454 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M S A Deloire, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, B Barroso, J-C Ouallet, C Pachai, E Galliaud, et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 519 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tiberio, D. T. Chard, D. R. Altmann, G. Davies, C. M. Griffin, W. Rashid, J. Sastre-Garriga, A. J. Thompson, and D. H. Miller Gray and white matter volume changes in early RRMS: A 2-year longitudinal study Neurology, March 22, 2005; 64(6): 1001 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pagani, M. A. Rocca, A. Gallo, M. Rovaris, V. Martinelli, G. Comi, and M. Filippi Regional Brain Atrophy Evolves Differently in Patients with Multiple Sclerosis According to Clinical Phenotype AJNR Am. J. Neuroradiol., February 1, 2005; 26(2): 341 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Petzold, M J Eikelenboom, G Keir, D Grant, R H C Lazeron, C H Polman, B M J Uitdehaag, E J Thompson, and G Giovannoni Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 206 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Diem, M. B. Sattler, D. Merkler, I. Demmer, K. Maier, C. Stadelmann, H. Ehrenreich, and M. Bahr Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis Brain, February 1, 2005; 128(2): 375 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Locatelli, R. Zivadinov, A. Grop, and M. Zorzon Frontal parenchymal atrophy measures in multiple sclerosis Multiple Sclerosis, October 1, 2004; 10(5): 562 - 568. [Abstract] [PDF]
|
|
|
|
|
|
W Rashid, L M Parkes, G T Ingle, D T Chard, A T Toosy, D R Altmann, M R Symms, P S Tofts, A J Thompson, and D H Miller Abnormalities of cerebral perfusion in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1288 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Amato, M. L. Bartolozzi, V. Zipoli, E. Portaccio, M. Mortilla, L. Guidi, G. Siracusa, S. Sorbi, A. Federico, and N. De Stefano Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment Neurology, July 13, 2004; 63(1): 89 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sharma, M. P. Sanfilipo, R. H. B. Benedict, B. Weinstock-Guttman, F. E. Munschauer III, and R. Bakshi Whole-Brain Atrophy in Multiple Sclerosis Measured by Automated versus Semiautomated MR Imaging Segmentation AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 985 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J N. Zwemmer, T van Veen, L van Winsen, G J van Kamp, F Barkhof, C H Polman, and B M. Uitdehaag No major association of A poE genotype with disease characteristics and MRI findings in multiple sclerosis Multiple Sclerosis, June 1, 2004; 10(3): 272 - 277. [Abstract] [PDF]
|
|
|
|
|
|
C. M. Dalton, D. T. Chard, G. R. Davies, K. A. Miszkiel, D. R. Altmann, K. Fernando, G. T. Plant, A. J. Thompson, and D. H. Miller Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes Brain, May 1, 2004; 127(5): 1101 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. De Stefano, M. L. Bartolozzi, B. Nacmias, V. Zipoli, M. Mortilla, L. Guidi, G. Siracusa, S. Sorbi, A. Federico, and M. P. Amato Influence of Apolipoprotein E {epsilon}4 Genotype on Brain Tissue Integrity in Relapsing-Remitting Multiple Sclerosis Arch Neurol, April 1, 2004; 61(4): 536 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Frank, N. Richert, C. Bash, L. Stone, P. A. Calabresi, B. Lewis, R. Stone, T. Howard, and H. F. McFarland Interferon-{beta}-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients Neurology, March 9, 2004; 62(5): 719 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Ingle, V. L. Stevenson, D. H. Miller, and A. J. Thompson Primary progressive multiple sclerosis: a 5-year clinical and MR study Brain, November 1, 2003; 126(11): 2528 - 2536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Nash, J. D. Bowen, P. A. McSweeney, S. Z. Pavletic, K. R. Maravilla, M.-s. Park, J. Storek, K. M. Sullivan, J. Al-Omaishi, J. R. Corboy, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis Blood, October 1, 2003; 102(7): 2364 - 2372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sailer, B. Fischl, D. Salat, C. Tempelmann, M. A. Schonfeld, E. Busa, N. Bodammer, H.-J. Heinze, and A. Dale Focal thinning of the cerebral cortex in multiple sclerosis Brain, August 1, 2003; 126(8): 1734 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Pelletier, S J Nelson, J Oh, J P Antel, M Kita, S S Zamvil, and D E Goodkin MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 950 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. De Stefano, P. M. Matthews, M. Filippi, F. Agosta, M. De Luca, M. L. Bartolozzi, L. Guidi, A. Ghezzi, E. Montanari, A. Cifelli, et al. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability Neurology, April 8, 2003; 60(7): 1157 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Turner, X. Lin, G. Calmon, N. Roberts, and L. D Blumhardt C erebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years Multiple Sclerosis, February 1, 2003; 9(1): 21 - 27. [Abstract] [PDF]
|
|
|
|
|
|
M.J. Eikelenboom, A. Petzold, R.H.C. Lazeron, E. Silber, M. Sharief, E.J. Thompson, F. Barkhof, G. Giovannoni, C.H. Polman, and B.M.J. Uitdehaag Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy Neurology, January 28, 2003; 60(2): 219 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Caon, M. Zvartau-Hind, W. Ching, R.P. Lisak, A.C. Tselis, and O.A. Khan Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis Neurology, January 28, 2003; 60(2): 323 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bergers, J.C.J. Bot, C.J.A. De Groot, C.H. Polman, G.J. Lycklama a Nijeholt, J.A. Castelijns, P. van der Valk, and F. Barkhof Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions Neurology, December 10, 2002; 59(11): 1766 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fisher, R. A. Rudick, J. H. Simon, G. Cutter, M. Baier, J. -C. Lee, D. Miller, B. Weinstock-Guttman, M. K. Mass, D. S. Dougherty, et al. Eight-year follow-up study of brain atrophy in patients with MS Neurology, November 12, 2002; 59(9): 1412 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E L. Hoogervorst, C H Polman, and F Barkhof Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone Multiple Sclerosis, October 1, 2002; 8(5): 415 - 419. [Abstract] [PDF]
|
|
|
|
|
|
R Leigh, J Ostuni, D Pham, A Goldszal, B K Lewis, T Howard, N Richert, H McFarland, and J A Frank Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences Multiple Sclerosis, October 1, 2002; 8(5): 420 - 429. [Abstract] [PDF]
|
|
|
|
|
|
P. Charles, R. Reynolds, D. Seilhean, G. Rougon, M. S. Aigrot, A. Niezgoda, B. Zalc, and C. Lubetzki Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain, September 1, 2002; 125(9): 1972 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Coyle and H-P. Hartung Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response Multiple Sclerosis, September 1, 2002; 8(1_suppl): 2 - 9. [Abstract] [PDF]
|
|
|
|
|
|
H. McFarland, F. Barkhof, J. Antel, and D. Miller The role of MRI as a surrogate outcome measure in multiple sclerosis Multiple Sclerosis, September 1, 2002; 8(1_suppl): 40 - 51. [Abstract] [PDF]
|
|
|
|
|
|
C M Dalton, P A Brex, R Jenkins, N C Fox, K A Miszkiel, W R Crum, J I O'Riordan, G T Plant, A J Thompson, and D H Miller Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis J. Neurol. Neurosurg. Psychiatry, August 1, 2002; 73(2): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Miller, F. Barkhof, J. A. Frank, G. J. M. Parker, and A. J. Thompson Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance Brain, August 1, 2002; 125(8): 1676 - 1695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Filippi and R. I. Grossman MRI techniques to monitor MS evolution: The present and the future Neurology, April 23, 2002; 58(8): 1147 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Arnold and P.M. Matthews MRI in the diagnosis and management of multiple sclerosis Neurology, April 23, 2002; 58(90084): S23 - 31. [Abstract] [Full Text]
|
|
|
|
|
|
P K Coyle and H-P Hartung Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response Multiple Sclerosis, February 1, 2002; 8(1): 2 - 9. [Abstract] [PDF]
|
|
|
|
|
|
H F McFarland, F Barkhof, J Antel, and D H Miller The role of MRI as a surrogate outcome measure in multiple sclerosis Multiple Sclerosis, February 1, 2002; 8(1): 40 - 51. [Abstract] [PDF]
|
|
|
|
|
|
D. T. Chard, C. M. Griffin, G. J. M. Parker, R. Kapoor, A. J. Thompson, and D. H. Miller Brain atrophy in clinically early relapsing-remitting multiple sclerosis Brain, February 1, 2002; 125(2): 327 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inglese, A. Ghezzi, S. Bianchi, S. Gerevini, M. P. Sormani, V. Martinelli, G. Comi, and M. Filippi Irreversible Disability and Tissue Loss in Multiple Sclerosis: A Conventional and Magnetization Transfer Magnetic Resonance Imaging Study of the Optic Nerves Arch Neurol, February 1, 2002; 59(2): 250 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Bermel, R. Bakshi, C. Tjoa, S. R. Puli, and L. Jacobs Bicaudate Ratio as a Magnetic Resonance Imaging Marker of Brain Atrophy in Multiple Sclerosis Arch Neurol, February 1, 2002; 59(2): 275 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zivadinov, R. A. Rudick, R. De Masi, D. Nasuelli, M. Ukmar, R. S. Pozzi-Mucelli, A. Grop, G. Cazzato, and M. Zorzon Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS Neurology, October 9, 2001; 57(7): 1239 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Kalkers, E. Bergers, J. A. Castelijns, M. A. A. van Walderveen, J. C. J. Bot, H. J. Ader, C. H. Polman, and F. Barkhof Optimizing the association between disability and biological markers in MS Neurology, October 9, 2001; 57(7): 1253 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Iannucci, M. Rovaris, L. Giacomotti, G. Comi, and M. Filippi Correlation of Multiple Sclerosis Measures Derived from T2-Weighted, T1-Weighted, Magnetization Transfer, and Diffusion Tensor MR Imaging AJNR Am. J. Neuroradiol., September 1, 2001; 22(8): 1462 - 1467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Whitwell, W. R. Crum, H. C. Watt, and N. C. Fox Normalization of Cerebral Volumes by Use of Intracranial Volume: Implications for Longitudinal Quantitative MR Imaging AJNR Am. J. Neuroradiol., September 1, 2001; 22(8): 1483 - 1489. [Abstract] [Full Text] [PDF]
|
|